Effects of Imatinib Mesylate in Polycythemia Vera

Summary

The purpose of this study is to determine the activity of Glivec 400 mg po daily, as single agent, in inducing a haematological response in Polycythemia Vera. The patients will be asked to have additional bone marrow and blood samples collected: these samples will be used to evaluate how the disease is responding to the drug.

Timeline

Start

2007-02

Primary completion

2009-11

Completion

2012-09

Drugs

Indications